Danaher Corp., US2358511028

Goldman Sachs raises target for Danaher stock to USD 250.00

Published on 10/01/2026 at 13:17 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Revenue rose 5.50 percent to USD 6.26 billion in the second quarter. Danaher stock costs EUR 195.18 on October 1, 2026 versus EUR 195.70.

Schwarz-Weiß-Reportagefoto eines Forschers am Mikroskop in einem klassischen Diagnostiklabor
Danaher Corp. Diagnostik-Labor US2358511028 in dokumentarischer Schwarzweiß-Reportage mit Forscher am alten Mikroskop, Illustration mit AI erstellt.

Goldman Sachs raised its price target for Danaher from USD 210.00 to USD 250.00 while maintaining a buy rating, according to MarketBeat on September 24, 2026. Danaher stock was at EUR 195.18 at Lang & Schwarz on October 1, 2026, down 0.27 percent versus the prior close.

Goldman target reaches USD 250

The target move gives Danaher a fresh analyst reference point as the company approaches its third-quarter update. MarketBeat reported that Goldman Sachs lifted the target from USD 210.00 to USD 250.00 and kept its buy rating; the source also cited a consensus Moderate Buy view and an average target of USD 230.23 based on 24 analyst ratings.

The spread of analyst views remains important because the target changes followed a mixed operating backdrop. Goldman Sachs placed the highest target cited in the report, while other firms carried targets ranging from USD 200.00 to USD 250.00, according to the same September 24, 2026 MarketBeat report.

Second-quarter revenue rose 5.50 percent

Danaher reported USD 6.26 billion of revenue in the second quarter of 2026, up 5.50 percent from the same period a year earlier. Earnings per share came to USD 1.94 against a consensus estimate of USD 1.85, a USD 0.09 comparison advantage, according to MarketBeat in its September 29, 2026 report.

The numbers make the upcoming report a test of whether revenue growth can support the higher analyst target. Danaher generated USD 1.53 billion of operating cash flow in the second quarter of 2026, compared with USD 1.32 billion in the first quarter of 2026, while the operating margin was 18.00 percent in the second quarter.

October 21 earnings date

Danaher has scheduled its third-quarter 2026 earnings conference call for October 21, 2026, beginning at 8:00 a.m. ET, according to the company's investor-relations release dated September 22, 2026. The timing gives investors a defined event for testing the revenue trajectory and the assumptions behind the USD 250.00 target.

Euro quote sits below prior close

At Lang & Schwarz, Danaher was trading at EUR 195.18 on October 1, 2026 at 1:08 p.m. CEST, down 0.27 percent from the prior close of EUR 195.70. The primary-market context was a USD 221.59 quote for September 30, 2026, with a 52-week range of USD 160.93 to USD 242.80 and market capitalization of USD 155.8 billion.

The further course of trading is shown by the continuously updated real-time quote of Danaher stock.

Danaher stock facts

  • Company: Danaher Corporation
  • ISIN: US2358511028
  • Ticker: DHR
  • Primary exchange: NYSE
  • Price Lang & Schwarz (as of October 1, 2026, 1:08 p.m. CEST): EUR 195.18
  • Change versus prior close: minus 0.27 percent
  • Prior close Lang & Schwarz (September 30, 2026): EUR 195.70
  • Market capitalization: USD 155.8 billion (as of September 30, 2026)
  • 52-week range: USD 160.93-242.80 (as of September 30, 2026)
  • Sector / Industry: Healthcare / Medical - Diagnostics & Research
  • Next earnings date: October 21, 2026

More news and analyses on Danaher stock

Disclaimer...

en | US2358511028 | DANAHER CORP. | boerse | 70210096 | bgmi